Profile | GDS4284 / 210758_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 461.234 | 63 |
GSM687648 | Patient 402 control | 343.337 | 58 |
GSM687653 | Patient 403 control | 401.941 | 61 |
GSM687658 | Patient 404 control | 683.871 | 68 |
GSM687663 | Patient 411 control | 411.717 | 60 |
GSM687668 | Patient 422 control | 361.833 | 59 |
GSM687673 | Patient 424 control | 708.788 | 68 |
GSM687678 | Patient 425 control | 390.199 | 59 |
GSM687683 | Patient 427 control | 357.326 | 57 |
GSM687688 | Patient 428 control | 433.253 | 62 |
GSM687695 | Patient 441 control | 396.333 | 56 |
GSM687699 | Patient 443 control | 385.808 | 58 |
GSM687704 | Patient 444 control | 591.013 | 66 |
GSM687707 | Patient 448 control | 443.658 | 61 |
GSM687712 | Patient 449 control | 578.928 | 66 |
GSM687719 | Patient 450 control | 418.342 | 59 |
GSM687724 | Patient 451 control | 656.335 | 68 |
GSM687728 | Patient 452 control | 543.581 | 65 |
GSM687646 | Patient 401 treated 24h | 417.456 | 60 |
GSM687649 | Patient 402 treated 24h | 345.295 | 58 |
GSM687665 | Patient 411 treated 24h | 444.622 | 61 |
GSM687651 | Patient 402 treated 4 weeks | 292.502 | 54 |
GSM687667 | Patient 411 treated 4 weeks | 503.435 | 63 |
GSM687670 | Patient 422 treated 24h | 376.549 | 58 |
GSM687671 | Patient 422 treated 4 weeks | 481.137 | 63 |
GSM687654 | Patient 403 treated 24h | 341.643 | 59 |
GSM687675 | Patient 424 treated 24h | 496.23 | 63 |
GSM687685 | Patient 427 treated 24h | 476.457 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 475.06 | 63 |
GSM687677 | Patient 424 treated 4 weeks | 459.992 | 62 |
GSM687687 | Patient 427 treated 4 weeks | 505.07 | 64 |
GSM687692 | Patient 428 treated 4h | 627.806 | 67 |
GSM687716 | Patient 449 treated 4h | 599.51 | 67 |
GSM687722 | Patient 450 treated 4h | 281.325 | 52 |
GSM687680 | Patient 425 treated 24h | 551.796 | 65 |
GSM687690 | Patient 428 treated 24h | 709.869 | 69 |
GSM687700 | Patient 443 treated 24h | 327.196 | 52 |
GSM687705 | Patient 444 treated 24h | 362.401 | 60 |
GSM687714 | Patient 449 treated 24h | 575.127 | 66 |
GSM687721 | Patient 450 treated 24h | 200.884 | 44 |
GSM687682 | Patient 425 treated 4 weeks | 447.606 | 62 |
GSM687694 | Patient 428 treated 4 weeks | 395.967 | 60 |
GSM687702 | Patient 443 treated 4 weeks | 476.61 | 62 |
GSM687718 | Patient 449 treated 4 weeks | 387.774 | 60 |
GSM687723 | Patient 450 treated 4 weeks | 543.661 | 65 |
GSM687661 | Patient 404 treated 4h | 786.049 | 70 |
GSM687710 | Patient 448 treated 4h | 799.45 | 71 |
GSM687726 | Patient 451 treated 4h | 879.002 | 72 |
GSM687730 | Patient 452 treated 4h | 768.547 | 68 |
GSM687660 | Patient 404 treated 24h | 542.597 | 66 |
GSM687697 | Patient 441 treated 24h | 388.764 | 57 |
GSM687709 | Patient 448 treated 24h | 1357.36 | 79 |
GSM687725 | Patient 451 treated 24h | 488.489 | 62 |
GSM687729 | Patient 452 treated 24h | 626.817 | 68 |
GSM687727 | Patient 451 treated 4 weeks | 669.573 | 68 |
GSM687731 | Patient 452 treated 4 weeks | 562.203 | 65 |